RESUMO
OBJECTIVE: This study aimed to elucidate how DHA enhances the radiosensitivity of BC and to explain its potential mechanisms of action. METHODS: The circular structure of hsa_circ_0001610 was confirmed by Sanger sequencing, RNase R treatment, RT-PCR analysis using gDNA or cDNA. Cellular localization of hsa_circ_0001610 and microRNA-139-5p (miR-139-5p) was detected by fluorescence in situ hybridization. Cell counting kit-8 assay, wound healing and colony formation tests for assessing cell proliferation, while flow cytometry was utilized to estimate cell cycle progression and apoptosis. Reactive oxygen species and malondialdehyde experiments were conducted to validate ferroptosis of BC cells. The expression of ncRNAs and mRNAs was quantified via qRT-PCR, and protein expression was analyzed using western blot. The effects of hsa_circ_0001610 and DHA on radiosensitivity of BC in vivo were studied by establishing BC mice model. RESULTS: In vivo and in vitro experimental results indicate that DHA promotes ferroptosis of BC cells at least partly by inhibiting hsa_circ_0001610/miR-139-5p/SLC7A11 pathway, thereby enhancing the radiosensitivity of BC cells. CONCLUSIONS: Our findings showed that DHA can induce ferroptosis of BC cells by down-regulation of hsa_circ_0001610, thus enhancing radiosensitivity, suggesting a promising therapeutic strategy for enhancing BC radiosensitivity that is worthy of further exploration.
RESUMO
The diagnosis of pneumoconiosis is complex and subjective, leading to inevitable variability in readings. This is especially true for inexperienced doctors. To improve accuracy, a computer-assisted diagnosis system is used for more effective pneumoconiosis diagnoses. Three models (Resnet50, Resnet101, and DenseNet) were used for pneumoconiosis classification based on 1250 chest X-ray images. Three experienced and highly qualified physicians read the collected digital radiography images and classified them from category 0 to category III in a double-blinded manner. The results of the 3 physicians in agreement were considered the relative gold standards. Subsequently, 3 models were used to train and test these images and their performance was evaluated using multi-class classification metrics. We used kappa values and accuracy to evaluate the consistency and reliability of the optimal model with clinical typing. The results showed that ResNet101 was the optimal model among the 3 convolutional neural networks. The AUC of ResNet101 was 1.0, 0.9, 0.89, and 0.94 for detecting pneumoconiosis categories 0, I, II, and III, respectively. The micro-average and macro-average mean AUC values were 0.93 and 0.94, respectively. The accuracy and Kappa values of ResNet101 were 0.72 and 0.7111 for quadruple classification and 0.98 and 0.955 for dichotomous classification, respectively, compared with the relative standard classification of the clinic. This study develops a deep learning based model for screening and staging of pneumoconiosis is using chest radiographs. The ResNet101 model performed relatively better in classifying pneumoconiosis than radiologists. The dichotomous classification displayed outstanding performance, thereby indicating the feasibility of deep learning techniques in pneumoconiosis screening.
Assuntos
Aprendizado Profundo , Pneumoconiose , Radiografia Torácica , Humanos , Pneumoconiose/diagnóstico por imagem , Pneumoconiose/diagnóstico , Radiografia Torácica/métodos , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Feminino , Diagnóstico por Computador/métodos , Idoso , Redes Neurais de ComputaçãoRESUMO
OBJECTIVES: To investigate the imaging characteristics and clinicopathological features of rim enhancement of breast masses demonstrated on contrast-enhanced mammography (CEM). METHODS: 67 cases of breast lesions confirmed by pathology and showing rim enhancement on CEM examinations were analyzed. The lesions were divided into benign and malignant groups, and the morphological and enhanced features were described. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated separately for each morphology descriptor to evaluate the diagnostic ability of each indicator. RESULTS: There were 35 (52.2%) malignant and 32 (47.8%) benign lesions. There are significant differences in the morphological and enhanced features between benign and malignant lesions. 29/35 (82.9%) malignant lesions exhibited irregular shapes, and 31/35 (88.6%) showed indistinct margins. 28/35 (80%) malignant lesions displayed strong enhancement on CEM, while 12/32 (37.5%) benign lesions exhibited weak enhancement (P = 0.001). Malignant lesions showed a higher incidence of unsmooth inner walls than benign lesions (28/35 vs 7/32; P <.001). Lesion margins showed high sensitivity of 88.57% and NPV of 81.8%. The presence of suspicious calcifications had the highest specificity of 100% and PPV of 100%. The diagnostic sensitivity, specificity, PPV, and NPV of the combined parameters were 97.14%, 93.15%, 94.44%, and 96.77%, respectively. CONCLUSIONS: The assessment of morphological and enhanced features of breast lesions exhibiting rim enhancement on CEM can improve the differentiation between benign and malignant breast lesions. ADVANCES IN KNOWLEDGE: This article provides a reference for the differential diagnosis of ring enhanced lesions on CEM.
Assuntos
Neoplasias da Mama , Meios de Contraste , Mamografia , Sensibilidade e Especificidade , Humanos , Feminino , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/patologia , Mamografia/métodos , Pessoa de Meia-Idade , Diagnóstico Diferencial , Adulto , Idoso , Estudos Retrospectivos , Mama/diagnóstico por imagem , Mama/patologiaRESUMO
Bone suppression is to suppress the superimposed bone components over the soft tissues within the lung area of Chest X-ray (CXR), which is potentially useful for the subsequent lung disease diagnosis for radiologists, as well as computer-aided systems. Despite bone suppression methods for frontal CXRs being well studied, it remains challenging for lateral CXRs due to the limited and imperfect DES dataset containing paired lateral CXR and soft-tissue/bone images and more complex anatomical structures in the lateral view. In this work, we propose a bone suppression method for lateral CXRs by leveraging a two-stage distillation learning strategy and a specific data correction method. Specifically, a primary model is first trained on a real DES dataset with limited samples. The bone-suppressed results on a relatively large lateral CXR dataset produced by the primary model are improved by a designed gradient correction method. Secondly, the corrected results serve as training samples to train the distillated model. By automatically learning knowledge from both the primary model and the extra correction procedure, our distillated model is expected to promote the performance of the primary model while omitting the tedious correction procedure. We adopt an ensemble model named MsDd-MAP for the primary and distillated models, which learns the complementary information of Multi-scale and Dual-domain (i.e., intensity and gradient) and fuses them in a maximum-a-posteriori (MAP) framework. Our method is evaluated on a two-exposure lateral DES dataset consisting of 46 subjects and a lateral CXR dataset consisting of 240 subjects. The experimental results suggest that our method is superior to other competing methods regarding the quantitative evaluation metrics. Furthermore, the subjective evaluation by three experienced radiologists also indicates that the distillated model can produce more visually appealing soft-tissue images than the primary model, even comparable to real DES imaging for lateral CXRs.
Assuntos
Radiografia Torácica , Tórax , Humanos , Radiografia Torácica/métodos , Raios X , Radiografia , Osso e OssosRESUMO
Objective: To compare and evaluate radiomics models to preoperatively predict ß-catenin mutation in patients with hepatocellular carcinoma (HCC). Methods: Ninety-eight patients who underwent preoperative gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI were retrospectively included. Volumes of interest were manually delineated on arterial phase, portal venous phase, delay phase, and hepatobiliary phase (HBP) images. Radiomics features extracted from different combinations of imaging phases were analyzed and validated. A linear support vector classifier was applied to develop different models. Results: Among all 15 types of radiomics models, the model with the best performance was seen in the RHBP radiomics model. The area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity of the RHBP radiomics model in the training and validation cohorts were 0.86 (95% confidence interval [CI], 0.75-0.93), 0.75, 1.0, and 0.65 and 0.82 (95% CI, 0.63-0.93), 0.73, 0.67, and 0.76, respectively. The combined model integrated radiomics features in the RHBP radiomics model, and signatures in the clinical model did not improve further compared to the single HBP radiomics model with AUCs of 0.86 and 0.76. Good calibration for the best RHBP radiomics model was displayed in both cohorts; the decision curve showed that the net benefit could achieve 0.15. The most important radiomics features were low and high gray-level zone emphases based on gray-level size zone matrix with the same Shapley additive explanation values of 0.424. Conclusion: The RHBP radiomics model may be used as an effective model indicative of HCCs with ß-catenin mutation preoperatively and thus could guide personalized medicine.
RESUMO
BACKGROUND: The present study aimed to investigate whether deep bone suppression imaging (BSI) could increase the diagnostic performance for solitary pulmonary nodule detection compared with digital tomosynthesis (DTS), dual-energy subtraction (DES) radiography, and conventional chest radiography (CCR). METHODS: A total of 256 patients (123 with a solitary pulmonary nodule, 133 with normal findings) were included in the study. The confidence score of 6 observers determined the presence or absence of pulmonary nodules in each patient. These were first analyzed using a CCR image, then with CCR plus deep BSI, then with CCR plus DES radiography, and finally with DTS images. Receiver-operating characteristic curves were used to evaluate the performance of the 6 observers in the detection of pulmonary nodules. RESULTS: For the 6 observers, the average area under the curve improved significantly from 0.717 with CCR to 0.848 with CCR plus deep BSI (P<0.01), 0.834 with CCR plus DES radiography (P<0.01), and 0.939 with DTS (P<0.01). Comparisons between CCR and CCR plus deep BSI found that the sensitivities of the assessments by the 3 residents increased from 53.2% to 69.5% (P=0.014) for nodules located in the upper lung field, from 30.6% to 44.6% (P=0.015) for nodules that were partially/completely obscured by the bone, and from 33.2% to 45.8% (P=0.006) for nodules <10 mm. CONCLUSIONS: The deep BSI technique can significantly increase the sensitivity of radiology residents for solitary pulmonary nodules compared with CCR. Increased detection was seen mainly for smaller nodules, nodules with partial/complete obscuration, and nodules located in the upper lung field.
RESUMO
As the coronavirus disease 2019 (COVID-19) epidemic spreads around the world, the demand for imaging examinations increases accordingly. The value of conventional chest radiography (CCR) remains unclear. In this study, we aimed to investigate the diagnostic value of CCR in the detection of COVID-19 through a comparative analysis of CCR and CT. This study included 49 patients with 52 CT images and chest radiographs of pathogen-confirmed COVID-19 cases and COVID-19-suspected cases that were found to be negative (non-COVID-19). The performance of CCR in detecting COVID-19 was compared to CT imaging. The major signatures that allowed for differentiation between COVID-19 and non-COVID-19 cases were also evaluated. Approximately 75% (39/52) of images had positive findings on the chest x-ray examinations, while 80.7% (42/52) had positive chest CT scans. The COVID-19 group accounted for 88.4% (23/26) of positive chest X-ray examinations and 96.1% (25/26) of positive chest CT scans. The sensitivity, specificity, and accuracy of CCR for abnormal shadows were 88%, 80%, and 87%, respectively, for all patients. For the COVID-19 group, the accuracy of CCR was 92%. The primary signature on CCR was flocculent shadows in both groups. The shadows were primarily in the bi-pulmonary, which was significantly different from non-COVID-19 patients (p = 0.008). The major CT finding of COVID-19 patients was ground-glass opacities in both lungs, while in non-COVID-19 patients, consolidations combined with ground-glass opacities were more common in one lung than both lungs (p = 0.0001). CCR showed excellent performance in detecting abnormal shadows in patients with confirmed COVID-19. However, it has limited value in differentiating COVID-19 patients from non-COVID-19 patients. Through the typical epidemiological history, laboratory examinations, and clinical symptoms, combined with the distributive characteristics of shadows, CCR may be useful to identify patients with possible COVID-19. This will allow for the rapid identification and quarantine of patients.
Assuntos
COVID-19/diagnóstico por imagem , Radiografia Torácica/métodos , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Radiografia Torácica/normas , Tomografia Computadorizada por Raios X/normasRESUMO
This study established an interpretable machine learning model to predict the severity of coronavirus disease 2019 (COVID-19) and output the most crucial deterioration factors. Clinical information, laboratory tests, and chest computed tomography (CT) scans at admission were collected. Two experienced radiologists reviewed the scans for the patterns, distribution, and CT scores of lung abnormalities. Six machine learning models were established to predict the severity of COVID-19. After parameter tuning and performance comparison, the optimal model was explained using Shapley Additive explanations to output the crucial factors. This study enrolled and classified 198 patients into mild (n = 162; 46.93 ± 14.49 years old) and severe (n = 36; 60.97 ± 15.91 years old) groups. The severe group had a higher temperature (37.42 ± 0.99°C vs. 36.75 ± 0.66°C), CT score at admission, neutrophil count, and neutrophil-to-lymphocyte ratio than the mild group. The XGBoost model ranked first among all models, with an AUC, sensitivity, and specificity of 0.924, 90.91%, and 97.96%, respectively. The early stage of chest CT, total CT score of the percentage of lung involvement, and age were the top three contributors to the prediction of the deterioration of XGBoost. A higher total score on chest CT had a more significant impact on the prediction. In conclusion, the XGBoost model to predict the severity of COVID-19 achieved excellent performance and output the essential factors in the deterioration process, which may help with early clinical intervention, improve prognosis, and reduce mortality.